Midazolam is a commonly used benzodiazepine in palliative care and is considered one of
the four essential drugs needed for the promotion of quality care in dying patients. Acting on …

Continuous deep sedation at the end of life is a specific form of palliative sedation requiring
a care plan that essentially places and maintains the patient in an unresponsive state …

'Palliation sedation'is a widely used term to describe the intentional administration of
sedatives to reduce a dying person's consciousness to relieve intolerable suffering from …

Context Limited information is available regarding the detailed clinical patterns of palliative
sedation (PS), that is, the symptom control rate, salvage medication, and the effectiveness of …

Background: Little research has explored the detail of practice when using sedative
medications at the end of life. One work package of the I-CAN-CARE research programme …

Aims Midazolam is the drug of choice for palliative sedation and is titrated to achieve the
desired level of sedation. Because of large inter‐individual variability (IIV), however, the time …

Background Palliative sedation is consciously reducing the patient's consciousness to
alleviate the refractory symptoms. However, studies on palliative sedation for children are …

Methoden Die methodische Konzeption des Vorhabens richtet sich an einem spezifischen
Verständnis von Praxisforschung aus: der partizipativen Forschung. Den partizipativen …

Background: A variety of terms and attitudes surround palliative sedation (PS) with little
research devoted to hospice and palliative care (HPC) clinicians' perceptions and …

Background Palliative sedation is used to relieve refractory symptoms and is part of clinical
practice in Sweden. Yet we do not know how frequently this practice occurs, how decision …